Nifty
:
22147.00
Sensex
:
73088.33
151.15 (0.69%)
599.34 (0.83%)
Nifty
Sensex
:
:
22147.00
73088.33
151.15 (0.69%)
599.34 (0.83%)

Zim Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
47/99

BSE: 541400 | NSE: ZIMLAB

NSE BSE
92.45
19-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  95.45
  •  96.45
  •  91.85
  •  95.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  292348
  •  273.57
  •  152.70
  •  73.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 450.42
  • 27.47
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 493.36
  • N/A
  • 1.95

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.26%
  • 6.70%
  • 49.01%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 11.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.73
  • 3.51
  • 9.06

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.16
  • 4.35
  • 5.51

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.45
  • 9.75
  • 49.44

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 24.11
  • 27.97

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.57
  • 1.99

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.15
  • 9.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
96.29
100.97
-4.64%
85.83
99.40
-13.65%
67.44
92.75
-27.29%
105.41
105.06
0.33%
Expenses
84.76
87.88
-3.55%
76.50
87.14
-12.21%
62.61
81.56
-23.23%
89.96
90.31
-0.39%
EBITDA
11.53
13.09
-11.92%
9.32
12.26
-23.98%
4.83
11.18
-56.80%
15.45
14.76
4.67%
EBIDTM
11.98%
12.97%
10.86%
12.34%
7.16%
12.06%
14.66%
14.04%
Other Income
1.11
2.40
-53.75%
1.42
1.42
0.00%
1.12
1.90
-41.05%
0.69
1.63
-57.67%
Interest
1.70
1.62
4.94%
1.22
1.36
-10.29%
1.73
1.33
30.08%
1.27
1.43
-11.19%
Depreciation
3.94
3.90
1.03%
4.09
4.37
-6.41%
4.03
4.27
-5.62%
4.93
4.18
17.94%
PBT
7.02
9.98
-29.66%
5.44
7.95
-31.57%
0.19
7.48
-97.46%
9.95
10.77
-7.61%
Tax
2.23
3.38
-34.02%
1.29
2.50
-48.40%
-0.04
2.33
-
2.71
3.74
-27.54%
PAT
4.79
6.60
-27.42%
4.15
5.45
-23.85%
0.23
5.15
-95.53%
7.24
7.03
2.99%
PATM
4.97%
6.54%
4.83%
5.48%
0.34%
5.55%
6.87%
6.69%
EPS
0.98
1.35
-27.41%
0.85
1.12
-24.11%
0.05
1.06
-95.28%
1.49
1.44
3.47%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
354.97
398.53
333.43
307.26
277.74
335.37
272.80
235.01
268.51
266.33
Net Sales Growth
-10.85%
19.52%
8.52%
10.63%
-17.18%
22.94%
16.08%
-12.48%
0.82%
 
Cost Of Goods Sold
164.81
198.83
160.35
158.63
143.14
159.51
140.89
119.96
157.72
181.51
Gross Profit
190.16
199.69
173.08
148.63
134.60
175.86
131.91
115.04
110.79
84.82
GP Margin
53.57%
50.11%
51.91%
48.37%
48.46%
52.44%
48.35%
48.95%
41.26%
31.85%
Total Expenditure
313.83
346.54
292.45
267.50
255.13
293.34
238.02
203.53
239.32
244.95
Power & Fuel Cost
-
11.09
9.14
7.04
7.47
7.19
5.75
5.35
6.40
6.33
% Of Sales
-
2.78%
2.74%
2.29%
2.69%
2.14%
2.11%
2.28%
2.38%
2.38%
Employee Cost
-
49.32
40.07
35.76
35.35
48.26
40.80
33.00
30.70
23.26
% Of Sales
-
12.38%
12.02%
11.64%
12.73%
14.39%
14.96%
14.04%
11.43%
8.73%
Manufacturing Exp.
-
33.83
29.03
23.40
26.97
13.62
7.82
7.76
7.25
7.18
% Of Sales
-
8.49%
8.71%
7.62%
9.71%
4.06%
2.87%
3.30%
2.70%
2.70%
General & Admin Exp.
-
19.55
15.82
10.72
11.61
14.53
10.85
10.30
8.61
6.21
% Of Sales
-
4.91%
4.74%
3.49%
4.18%
4.33%
3.98%
4.38%
3.21%
2.33%
Selling & Distn. Exp.
-
27.94
32.70
27.96
24.51
45.61
28.22
22.53
22.04
16.70
% Of Sales
-
7.01%
9.81%
9.10%
8.82%
13.60%
10.34%
9.59%
8.21%
6.27%
Miscellaneous Exp.
-
5.98
5.35
3.98
6.07
4.62
3.69
4.62
6.60
3.76
% Of Sales
-
1.50%
1.60%
1.30%
2.19%
1.38%
1.35%
1.97%
2.46%
1.41%
EBITDA
41.13
51.99
40.98
39.76
22.61
42.03
34.78
31.48
29.19
21.38
EBITDA Margin
11.59%
13.05%
12.29%
12.94%
8.14%
12.53%
12.75%
13.40%
10.87%
8.03%
Other Income
4.34
6.41
4.40
2.34
4.52
2.05
3.42
5.51
3.91
2.48
Interest
5.92
5.58
8.31
10.90
12.65
10.59
9.34
10.47
13.65
10.32
Depreciation
16.99
17.47
16.03
15.79
14.41
11.42
9.79
9.02
8.76
7.13
PBT
22.60
35.35
21.04
15.41
0.07
22.07
19.07
17.50
10.69
6.41
Tax
6.19
10.92
6.49
2.91
-3.23
6.73
5.83
-1.09
0.26
-5.00
Tax Rate
27.39%
30.89%
30.85%
28.45%
-4614.29%
30.49%
23.39%
-6.23%
4.85%
18.79%
PAT
16.41
24.43
14.55
7.32
3.30
15.34
19.11
18.59
5.10
-21.61
PAT before Minority Interest
16.41
24.43
14.55
7.32
3.30
15.34
19.11
18.59
5.10
-21.61
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.62%
6.13%
4.36%
2.38%
1.19%
4.57%
7.01%
7.91%
1.90%
-8.11%
PAT Growth
-32.27%
67.90%
98.77%
121.82%
-78.49%
-19.73%
2.80%
264.51%
-
 
EPS
3.37
5.02
2.99
1.50
0.68
3.15
3.92
3.82
1.05
-4.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
200.35
175.71
160.75
153.82
151.12
136.60
118.33
98.96
94.21
Share Capital
48.73
16.24
16.24
16.18
16.12
8.06
8.03
8.00
8.00
Total Reserves
151.62
159.47
144.51
137.28
133.77
127.95
109.59
90.34
86.21
Non-Current Liabilities
36.74
20.01
19.40
22.72
20.19
16.61
18.09
34.75
37.59
Secured Loans
24.62
18.92
21.83
27.01
19.14
15.91
26.75
33.98
36.77
Unsecured Loans
0.00
0.00
0.00
0.41
3.02
4.37
0.77
0.77
0.82
Long Term Provisions
6.29
0.00
0.01
0.00
0.10
0.00
0.00
0.00
0.00
Current Liabilities
110.79
147.37
142.04
143.44
156.40
141.40
113.21
123.65
134.38
Trade Payables
58.24
81.07
64.87
66.00
71.95
66.26
45.05
46.97
64.12
Other Current Liabilities
29.07
44.71
31.16
26.68
38.65
25.15
18.33
16.71
17.24
Short Term Borrowings
22.88
17.34
44.60
49.69
40.15
49.56
46.70
56.30
51.42
Short Term Provisions
0.59
4.24
1.40
1.06
5.65
0.43
3.14
3.68
1.61
Total Liabilities
347.88
343.09
322.19
319.98
327.71
294.61
249.63
257.36
266.18
Net Block
108.66
105.64
106.52
115.92
106.01
94.16
88.75
92.19
87.11
Gross Block
198.66
180.24
165.49
159.23
135.67
112.90
97.77
120.36
107.50
Accumulated Depreciation
90.01
74.60
58.97
43.31
29.66
18.74
9.02
28.17
20.39
Non Current Assets
156.92
129.49
130.43
137.94
132.39
121.68
95.86
102.02
96.71
Capital Work in Progress
26.99
11.74
10.68
9.62
13.32
8.29
3.82
2.93
5.62
Non Current Investment
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Long Term Loans & Adv.
20.70
11.78
11.32
10.40
11.72
17.33
2.35
6.36
3.65
Other Non Current Assets
0.52
0.28
1.85
1.95
1.29
1.84
0.87
0.48
0.28
Current Assets
190.95
213.59
191.76
182.03
195.32
172.94
153.77
155.34
169.46
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
53.71
75.28
54.35
56.39
55.05
51.56
35.47
37.72
46.10
Sundry Debtors
95.25
89.52
72.25
67.93
93.10
89.22
88.18
88.53
81.29
Cash & Bank
7.52
4.97
8.35
3.95
2.94
3.53
5.61
6.39
7.69
Other Current Assets
34.48
1.41
1.55
1.60
44.23
28.63
24.52
22.70
34.39
Short Term Loans & Adv.
31.96
42.41
55.26
52.16
42.83
27.51
23.51
21.49
33.92
Net Current Assets
80.16
66.23
49.72
38.60
38.92
31.54
40.56
31.69
35.09
Total Assets
347.87
343.08
322.19
319.97
327.71
294.62
249.63
257.36
266.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
37.52
49.21
31.85
21.92
34.94
36.68
32.07
21.94
PBT
35.35
21.04
15.41
0.07
22.07
24.94
17.50
5.36
Adjustment
22.16
22.01
25.79
26.25
23.82
12.84
20.78
29.04
Changes in Working Capital
-12.84
6.58
-8.24
0.56
-9.64
2.96
-3.72
-11.32
Cash after chg. in Working capital
44.67
49.64
32.96
26.87
36.25
40.73
34.56
23.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-7.15
-0.43
-1.11
-4.96
-1.31
-4.06
-2.49
-1.14
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-36.20
-14.57
-5.88
-19.41
-20.68
-25.83
-7.24
-11.73
Net Fixed Assets
-32.76
-15.55
-7.23
-19.28
-22.29
-19.60
21.70
Net Investments
0.00
-0.10
0.00
-3.54
-4.45
0.00
0.00
Others
-3.44
1.08
1.35
3.41
6.06
-6.23
-28.94
Cash from Financing Activity
0.55
-32.97
-25.97
-2.16
-15.16
-9.80
-25.15
-10.35
Net Cash Inflow / Outflow
1.86
1.66
0.00
0.35
-0.90
1.04
-0.32
-0.14
Opening Cash & Equivalents
3.42
1.39
1.46
0.50
1.47
0.42
0.74
0.88
Closing Cash & Equivalent
6.42
3.42
1.39
1.46
0.50
1.47
0.42
0.74

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
41.12
36.06
32.99
94.84
92.99
84.38
73.25
61.47
58.89
ROA
7.07%
4.37%
2.28%
1.02%
4.93%
7.02%
7.33%
1.95%
-8.12%
ROE
13.00%
8.65%
4.66%
2.17%
10.73%
15.07%
17.21%
5.29%
-22.94%
ROCE
16.82%
12.52%
8.70%
5.39%
14.64%
16.46%
14.20%
9.95%
-8.70%
Fixed Asset Turnover
2.10
1.93
1.89
1.88
2.70
2.60
2.21
2.43
2.56
Receivable days
84.61
88.55
83.26
105.81
99.21
118.05
133.84
112.03
107.85
Inventory Days
59.07
70.95
65.77
73.23
58.02
57.91
55.43
55.29
61.16
Payable days
127.86
166.10
150.56
175.89
88.19
86.92
85.73
87.08
96.17
Cash Conversion Cycle
15.82
-6.61
-1.53
3.15
69.04
89.04
103.54
80.25
72.85
Total Debt/Equity
0.30
0.29
0.50
0.59
0.52
0.60
0.68
0.98
0.99
Interest Cover
7.34
3.53
1.94
1.01
3.08
3.67
2.67
1.39
-1.58

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Zim Laboratories - Quarterly Results
    29th Jan 2024, 16:15 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.